title: Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
abstract: BACKGROUND
  To investigate the-one year outcome of PTA and stenting and PTA alone for femoropopliteal occlusions.
  
  
  METHODS
  Randomized prospective study
  
  
  METHODS
  32 patients with femoropopliteal occlusions were randomized into two treatment groups: PTA and Strecker-stent (n=15) and PTA alone (n=17). The median age of the patients was 71 years. All patients had chronic limb ischaemia, 66% had tissue loss, 19% had rest pain and 15% had disabling claudication. The median ABPI was 0.45. The occlusion was confined to the superficial femoral artery in 30 cases and to the popliteal artery in 2 cases. The median length of the occlusions was 7.3 cm. Aspirin (ASA), 160 mg daily, was administrated postoperatively but no anticoagulation was used. The follow-up included: clinical examination, measurement of ABPI and control angiography at 12 months or earlier when necessary (20 patients).
  
  
  RESULTS
  There was no mortality or limb loss as a consequence of the treatment. There were six (16%) immediate major complications in five patients. In the PTA group, one patient had a myocardial infarction and three patients needed arteriography due to bleeding. In the stent group, one patient required arteriography and embolectomy. The one-year mortality was 6% and there were no amputations. Four patients (two in each group) were operated on with a femorodistal bypass. The rate of clinical improvement was 71% after PTA and stent and 60% after PTA alone (p=0.17). An increased ABPI (>0.10) was shown in 50% of the stent group and 61% in the PTA group (p=0.17). Angiographic re-occlusions were seen in 33% and 75% in the stent and PTA groups respectively (p=0.17), while the rate of restenosis was significantly higher in the stent group (50% vs 25%) (p=0.033).
  
  
  CONCLUSIONS
  Stenting following PTA for femoropopliteal occlusions does not significantly improve neither the clinical state nor the clinical/angiographic patency. The results do not justify any routine placement of stent following PTA in the successfully recanalized femoropopliteal arteries. The low rate of acceptance of a follow-up angiography indicates that this kind of study should preferably use duplex scanning instead of angiography for follow-up.
authors.affiliation: Department of Surgery, Lund University, Sweden.
authors.forename: Z
authors.initials: Z
authors.lastname: Zdanowski
authors.forename: U
authors.initials: U
authors.lastname: Albrechtsson
authors.forename: A
authors.initials: A
authors.lastname: Lundin
authors.forename: T
authors.initials: T
authors.lastname: Jonung
authors.forename: E
authors.initials: E
authors.lastname: Ribbe
authors.forename: J
authors.initials: J
authors.lastname: Thörne
authors.forename: L
authors.initials: L
authors.lastname: Norgren
mesh_terms: D000368:Aged; D000800:Angioplasty, Balloon; D001157:Arterial Occlusive Diseases / Q000401:mortality / Q000628:therapy*; D005260:Female; D005263:Femoral Artery; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011150:Popliteal Artery; D011183:Postoperative Complications / Q000453:epidemiology; D011446:Prospective Studies; D012008:Recurrence; D015607:Stents; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome